Michel Aubanel | Molecular Mechanisms Signaling | Research Excellence Award

Published on by Cell Biologist

Mr. Michel Aubanel | Molecular Mechanisms Signaling | Research Excellence Award

Kerry | France

Michel Aubanel is a senior R&D and innovation leader with more than three decades of experience in the flavors, ingredients, and aroma chemicals industry. He has held global leadership roles across major multinational organizations, driving process development, natural extract innovation, flavor optimization, and analytical research. His expertise spans natural and nature-identical molecules, botanical extracts, taste technologies, and advanced flavor delivery systems, with strong involvement in intellectual property creation and patent development. He has led multidisciplinary teams across Europe and the United States and supported global technology deployment across Asia, Africa, and emerging markets, particularly for alcoholic beverages. A recognized contributor to the scientific community, he serves on international science and flavor boards and is an active member of multiple professional chemical societies. His work is reflected in peer-reviewed toxicological publications and granted patents, highlighting a strong commitment to safety, innovation, and sustainable flavor solutions.

Citation Metrics (Scopus)

100
75
50
25
10
0

Citations
59

Documents
7

h-index
3

Citations

Documents

h-index

Featured Publication

Lin Wu | Bone Tissue Engineering | Excellence in Research Award

Published on by Cell Biologist

Ms. Lin Wu | Bone Tissue Engineering | Excellence in Research Award

Department of Stomatology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, P.R | China

Professor Wu Lin is a leading scholar in oral rehabilitation and biomaterials research, recognized for her extensive contributions to bone implant materials and advanced technologies for dental restoration. Her work spans more than 90 peer-reviewed publications across high-impact national and international journals, reflecting sustained productivity and influence in stomatology research. She has led major scientific initiatives, including national natural science projects, a “14th Five-Year Plan” National Key R&D project, national disaster-related research, multiple sub-projects under the national “863” Plan, and several provincial-level grants. As the first inventor, she holds two authorized invention patents that advance the design and performance of oral implant systems. Her editorial roles in multiple scientific journals and participation in specialized professional committees further demonstrate her leadership in shaping research directions in oral medicine, prosthodontics, and biomaterials science. Through her innovations, Professor Wu has significantly advanced clinical applications and material technologies in modern stomatology.

Citation Metrics (Scopus)
800

600

400

200

0

Citations
719

Documents
50

h-index
15

Citations
Documents
h-index



View Scopus Profile


Featured Publications

Junning Ma | Cell Surface Receptors | Best Research Article Award

Published on by Cell Biologist

Dr. Junning Ma | Cell Surface Receptors | Best Research Article Award

Zhejiang University | China

Dr. Junning Ma has developed a multidisciplinary portfolio spanning neurosurgery, neural engineering, biomaterials, and nanomedicine. Their work integrates neural stem cell biology, targeted drug delivery, and tumor microenvironment modulation to create innovative therapeutic strategies for brain diseases. They have conducted advanced postdoctoral and doctoral research at major institutions, contributing to National Natural Science Foundation of China (NSFC) Youth Fund projects and multiple US-funded NIH and AHA grants. Their research focuses on biomimetic nanocarriers, including cell membrane-coated nanoparticles, PLGA-based delivery systems, and fusion-membrane technologies designed for precision therapy of glioma, pituitary adenoma, and ischemic stroke.

Key projects include engineered neural stem cell membrane-coated nanoparticles for stroke targeting, biomimetic nanoplatforms for cancer immunotherapy, and tumor microenvironment–responsive delivery systems. They have also contributed to studies on neuromodulation, neurotrophic factor-based therapy, neural stem cell transplantation, and photothrombotic stroke models. Their publication record includes high-impact journals such as Materials Today Bio, Biomaterials, Nano Letters, Small, and Cell Reports Physical Science, covering topics like vascular-targeting nanoclusters, polyphenol nanoparticles, and membrane-engineered carriers.

Overall, their research advances translational nanomedicine and regenerative neuroscience, with an emphasis on targeted therapies capable of overcoming the challenges of brain tumor heterogeneity, the blood–brain barrier, and ischemic neural injury.

Profiles: Scopus | Orcid

Featured Publications: 

Ma, J., Win, Y., Xiaojian, Z., et al. (2023). Enhanced EPR effects by folliculostellate cell membrane–coated nanoparticles on invasive pituitary adenoma. Materials Today Bio.

Ma, J., Dai, L., Jianbo, Y., et al. (2023). Tumor microenvironment targeting system for glioma treatment via fusion cell membrane coating nanotechnology. Biomaterials.

Ma, J., Liu, F., Wendy, C., et al. (2020). Co-presentation of tumor antigens with costimulation via biomimetic nanoparticles for effective cancer immunotherapy. Nano Letters.

Ma, J., Zhang, S., Jun, L., et al. (2019). Targeted drug delivery to stroke via chemotactic recruitment of nanoparticles coated with membranes of engineered neural stem cells. Small.

Ilaria Cossu | Immunology Cellular Interactions | Research Excellence Award

Published on by Cell Biologist

Ms. Ilaria Cossu | Immunology Cellular Interactions | Research Excellence Award

University of Sassari | Italy

Ilaria Cossu is a motivated PhD candidate in Life Sciences and Biotechnologies with a specialization in Microbiology and Immunology. Their work focuses on understanding the role of human endogenous retroviruses (HERVs) in cancer, integrating molecular biology, immunology, and virology approaches to explore how retroviral elements may influence tumorigenesis. Their doctoral project involves conducting indirect ELISA assays, maintaining and analyzing cell cultures, processing blood samples, performing RNA extraction and reverse transcription, and carrying out quantitative PCR for gene expression profiling. The researcher is actively engaged in experimental design, data analysis, scientific writing, and collaborative research activities at both national and international levels.

Prior academic training includes Master’s and Bachelor’s degrees in Biology, each completed with top distinction, and research internships in microbiology, virology, and biochemistry laboratories. These experiences provided hands-on expertise in electrophoretic methods such as cellulose acetate electrophoresis, C-PAGE, fluorescent 2-aminoacridone probe (FACE) analysis, and SDS-PAGE, contributing to a solid foundation in protein and nucleic acid characterization. Their current research aims to advance understanding of retroviral contributions to cancer biology and supports the development of innovative molecular approaches for disease investigation and potential therapeutic insights.

Profile: Scopus

Featured Publications:

Cossu, I., Ruberto, S., Filippi, E., Simula, E. R., Noli, M., Mottula, A., & others. (2025). HERV-K envelope induces a humoral response in Non-Hodgkin lymphoma patients. Current Microbiology, 82(12), 574.

Jasemi, S., Molicotti, P., Fais, M., Cossu, I., Simula, E. R., Sechi, L. A., & others. (2025). Biological mechanisms of enterotoxigenic Bacteroides fragilis toxin: Linking inflammation, colorectal cancer, and clinical implications. Toxins, 17(6), 305.

Simula, E. R., Jasemi, S., Cossu, D., Fais, M., Cossu, I., Chessa, V., & others. (2025). Human endogenous retroviruses as novel therapeutic targets in neurodegenerative disorders. Vaccines, 13(4), 415. h

Ruberto, S., Santovito, A., Caviglia, G. P., Noli, M., Cossu, D., Ribaldone, D. G., & others. (2025). Mycobacterium avium subsp. paratuberculosis and human endogenous retrovirus in Italian patients with inflammatory bowel disease and irritable bowel syndrome. Immunology.

Mohamed Dammak | Cell Structure Analysis | Best Academic Researcher Award

Published on by Cell Biologist

Prof. Dr. Mohamed Dammak | Cell Structure Analysis | Best Academic Researcher Award

Faculty of Sciences of Sfax | Tunisia

Professor Mohamed Dammak is a distinguished researcher in the field of chemistry, recognized for his significant contributions to materials science, solid-state chemistry, and nanomaterials. His research primarily focuses on the synthesis, structural characterization, and optical properties of functional materials, including luminescent phosphors, glass ceramics, and doped oxide systems. He has extensively investigated rare-earth-doped materials for photonic and optoelectronic applications, contributing valuable insights into energy transfer mechanisms and material stability under various conditions. Professor Dammak’s scholarly output includes numerous publications in high-impact journals indexed in SCI and Scopus, reflecting his consistent pursuit of scientific excellence. With over 1,100 citations and an h-index of 17, his work has had a measurable influence on contemporary research in materials chemistry. He has also participated in national and international research collaborations, enhancing cross-disciplinary approaches to the development of advanced materials with optical and structural functionalities. Through his academic leadership and commitment to innovation, Professor Dammak continues to advance the understanding and application of inorganic and functional materials, bridging the gap between fundamental research and technological development in the field of chemistry.

Profile: Scopus

Featured Publications:

Dammak, M.*, Abdelmoula, N., Cheikhrouhou-Koubaa, W., & Cheikhrouhou, A. (2021). Short-range magnetic behavior in manganites La₀.₉₃K₀.₀₇Mn₁₋ₓCuₓO₃ (0.0 ≤ x ≤ 0.09) above the Curie temperature. Journal of Physics D: Applied Physics, 54(32), 325002. https://doi.org/10.1088/1361-6463/ac015c

 

Emine Mine Soylu | Plant Pathology | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Emine Mine Soylu | Plant Pathology | Best Researcher Award

Hatay Mustafa Kemal University | Turkey

Prof. Dr. Emine Mine Soylu is a prominent academic in the field of plant pathology, with a career spanning over three decades dedicated to plant protection, host-pathogen interactions, and disease management strategies in crops. She began her professional journey as a Research Assistant at Akdeniz University and has since contributed significantly to scientific research through both experimental studies and scholarly publications. Her work is widely recognized, with a particular focus on the identification and control of fungal and bacterial diseases in economically important plants. Prof. Soylu has published 54 scientific documents in internationally refereed journals and has amassed a total of 3,749 citations, reflecting the substantial impact of her work in the field. Her h-index is 25, indicating consistent and high-quality contributions to science over the years. Her research includes first reports of various plant diseases in Türkiye and in-depth studies on disease resistance mechanisms and biochemical plant responses. Prof. Soylu’s contributions continue to shape the future of sustainable agriculture and plant health, and her collaborations extend across national and international scientific communities. Her scholarly output and citation metrics demonstrate her strong influence in the field of phytopathology and plant-microbe interactions.

Profiles: Google Scholar | Scopus |  Orcid

Featured Publications:

  • “Preliminary Characterization of Race-Specific Elicitors From Peronospora parasitica and Its Ability to Elicit Phenolic Accumulation in Arabidopsis”

  • “First Report of Downy Leaf Spot of Walnuts Caused by Microstroma juglandis in Turkey”

  • “Induction of Disease Resistance by the Plant Activator, Acibenzolar-S-methyl (ASM), Against Bacterial Canker (Clavibacter michiganensis subsp. michiganensis) in Tomato Seedlings”

  • “First Report of Powdery Mildew Caused by Erysiphe heraclei on Dill (Anethum graveolens) in Turkey”

  • “Light and Electron Microscopy of the Compatible Interaction Between Arabidopsis and the Downy Mildew Pathogen Peronospora parasitica”

  • “Induction of Defence Related Enzymes and Resistance by the Plant Activator Acibenzolar-S-methyl in Tomato Seedlings Against Bacterial Canker Caused by Clavibacter michiganensis subsp. michiganensis”

  • “First Report of Cercospora Leaf Spot on Swiss Chard Caused by Cercospora beticola in Turkey”

  • “First Report of Phloeospora Leaf Spot on Mulberry Caused by Phloeospora maculans (=Cylindrosporium maculans) in the Eastern Mediterranean Region of Turkey”

  • “Induction of Disease Resistance and Antioxidant Enzymes by Acibenzolar-S-methyl Against Bacterial Canker (Clavibacter michiganensis subsp. michiganensis) in Tomato”

  • “First Report of Powdery Mildew Caused by Podosphaera phaseoli (syn. Sphaerotheca phaseoli) on Cowpea (Vigna sinensis) in Turkey”

 

 

 

 

 

 

 

 

 

 

Sevgi Kolayli | Microbiology | Best Researcher Award

Published on by Cell Biologist

Ms. Sevgi Kolayli | Microbiology | Best Researcher Award

Ms. Sevgi Kolayli | Karadeniz Technical University | Turkey

Prof. Dr. Sevgi Kolaylı is a distinguished biochemist and food scientist at Karadeniz Technical University, Turkey. With a career spanning over 25 years, she has made pioneering contributions in the fields of antioxidant activity, natural product chemistry, and food biochemistry, especially with respect to bee products such as honey, propolis, and bee bread. Her research explores the biochemical properties and therapeutic potentials of these natural substances, integrating analytical chemistry with toxicology and nutrition. She has authored numerous articles in international journals, demonstrating her scientific leadership and collaborative spirit. Dr. Kolaylı’s work not only furthers academic understanding but also provides practical insights into functional foods, public health, and sustainable agriculture. Recognized for her scientific excellence and innovation, she continues to mentor students and researchers, contributing significantly to science at national and global levels.

Publication Profiles: 

Orcid
Google Scholar
Scopus

Education:

Prof. Dr. Sevgi Kolaylı completed her undergraduate studies in Chemistry at Karadeniz Technical University, Turkey. She pursued postgraduate studies in Biochemistry, earning her Master’s and Ph.D. from the same institution. Her doctoral research focused on the biochemical analysis of natural products and their antioxidant capacities, with a special emphasis on enzymatic activities in fish and bioactive compounds in plant sources. Over the years, she has expanded her academic portfolio by attending international workshops, symposia, and scientific training, continually refining her skills in analytical methods such as chromatography, spectroscopy, and molecular characterization. Her solid educational foundation has enabled her to bridge the gap between traditional biochemical research and applied nutritional science. She remains actively engaged in academic development through her roles in teaching, supervision, and curriculum innovation at Karadeniz Technical University.

Experience:

Prof. Dr. Sevgi Kolaylı has served in various academic and research capacities at Karadeniz Technical University. Starting as a research assistant, she has risen through the academic ranks to become a full professor. Her career includes teaching undergraduate and postgraduate courses in biochemistry, food chemistry, and analytical techniques, while also supervising numerous MSc and PhD theses. Dr. Kolaylı has been a principal investigator in several national and international research projects focused on the bioactivity and safety of food-based natural compounds. She is a respected reviewer for several peer-reviewed journals and has collaborated with researchers from Algeria, Germany, and across Türkiye. Her strong laboratory and analytical experience, combined with leadership in scientific projects, underscore her capacity for impactful research. Additionally, she contributes to scientific committees, journal editorial boards, and serves as an evaluator for research funding bodies.

Research Focus:

Prof. Dr. Sevgi Kolaylı’s research centers on the biochemical evaluation of natural products, particularly those derived from bee-related sources such as honey, propolis, and bee bread. Her investigations focus on antioxidant activity, phenolic content, and bioactive characterization, aiming to understand their therapeutic and nutritional value. She uses advanced analytical techniques (e.g., HPLC, HRMS, spectrophotometry) to identify bioactive compounds and assess their antioxidant, antimicrobial, antiviral, and anticancer potentials. A significant portion of her work has examined regional differences in natural products, correlating botanical origin with chemical composition. Her newer research explores food enrichment using natural antioxidants and toxicity assessments of honey containing grayanotoxins. This multidisciplinary approach integrates food science, toxicology, and molecular biology, contributing to the development of functional foods and nutraceuticals. Prof. Kolaylı’s scientific vision is geared towards advancing public health through safe, natural, and effective bioactive substances.

Publications Top Notes: 

  1.  Comparative study on antioxidant enzyme activities and lipid peroxidation in different fish species – Turkish J. Zoology

  2.  Antioxidant enzymes in freshwater vs. seawater adapted trout – J. Biochem. Mol. Toxicol.

  3.  Chemical & antioxidant properties of cherry laurel fruit – J. Agric. Food Chem.

  4.  Does caffeine bind to metal ions? – Food Chemistry

  5.  Stereoselective photochemistry of methoxy chalcones – Turkish J. Chemistry

  6.  Essential oils of Centaurea spp. and their antimicrobial activity – Phytochemistry

  7.  Photocyclization and microbial activity of chalconoid compounds – J. Photochem. Photobiol. A

  8.  Synthesis of heterocycles as antioxidant/anticancer agents – Archiv der Pharmazie

  9.  Synthesis and antioxidant activities of triazol-5-one derivatives – Indian J. Chemistry

  10.  New triazole derivatives and their antioxidant properties – Asian J. Chemistry

Conclusion:

In conclusion, Prof. Dr. Sevgi Kolaylı exemplifies the qualities of a well-rounded, impactful, and visionary researcher whose work has significantly advanced the understanding of bioactive compounds in food and natural products. Her sustained excellence in publishing, mentoring, and interdisciplinary collaboration makes her highly suitable for the Best Researcher Award. Her ability to combine fundamental biochemical insights with real-world health applications, especially in the areas of antioxidant research and bee product functionality, showcases her as not just a researcher, but a contributor to global health and nutrition science. With minor enhancements in innovation dissemination and global visibility, she can further establish herself as a leading figure in the international scientific community. Based on the strength of her scientific record, impact, and innovation potential, she is a highly deserving nominee for the Best Researcher Award.

 

 

Marwa Aly | Bacterial Extracellular Vesicles | Best Researcher Award

Published on by Cell Biologist

Dr. Marwa Aly | Bacterial Extracellular Vesicles | Best Researcher Award

Dr. Marwa Aly | HB Fuller | United States

Dr. Marwa Aly (published as Marwa Gamal Saad), Ph.D., is a Senior Scientist at H.B. Fuller Company with an impressive interdisciplinary background spanning microbiology, bioengineering, nanotechnology, and biotechnology. She holds dual Ph.D. degrees from Port Said University (with research at Texas A&M University) and Washington State University, where she recently completed a thesis on bacterial extracellular vesicles targeting drug-resistant pathogens. Dr. Aly has authored multiple high-impact publications, secured substantial research funding, and contributed to patent-pending technologies. Her innovative work bridges the gap between microbial research and real-world applications, such as alternative biofuels and novel antimicrobials. With an h-index of 6 and over 250 citations, she has demonstrated consistent scientific impact. Recognized by prestigious awards like the Cougar Cage Award and WSU President’s Leadership Award, Dr. Aly is an emerging thought leader in microbial biotechnology, making her a prime candidate for the Best Researcher Award.

Publication Profiles:

Google Scholar
Scopus
Orcid

Education:

Dr. Marwa Aly holds two Doctor of Philosophy degrees in advanced scientific disciplines. She earned her first Ph.D. in Botany from Port Said University, Egypt, with collaborative research at Texas A&M University, USA. Her research focused on sustainable biofuel production from microalgae using nanotechnology and genetic engineering. She recently completed a second Ph.D. in Engineering from Washington State University, USA. Her dissertation investigated bacterial extracellular vesicles and their potential as next-generation antimicrobials against drug-resistant pathogens. Dr. Aly’s dual doctoral qualifications reflect her interdisciplinary expertise and commitment to solving complex global challenges. Her educational journey is marked by innovation, academic rigor, and successful translation of research into real-world impact.

Research Experience:

As a Graduate Assistant at Washington State University in Dr. Wen-Ji Dong’s Lab, Dr. Aly has pioneered research on microbial extracellular vesicles (EVs), securing a provisional patent and winning $100,000 in Cougar Cage funding. Her work involves in vitro and in vivo analysis of EVs from Pseudomonas aeruginosa, exploring their antimicrobial action, especially against Candida auris and drug-resistant pathogens. She also studies the role of ferroptosis in EV-mediated treatment strategies and has led proteomic profiling of bacterial biofilms. In her earlier Ph.D. work, she developed methods for microalgae-based biodiesel production using advanced microfluidics and nanotechnology. Her multidisciplinary research blends microbiology, chemical engineering, and biotechnology to address critical challenges in public health and sustainable energy. Her scientific contributions are recognized globally, making her a strong contender for research excellence.

Awards and Honors:

Dr. Marwa Aly has received multiple prestigious accolades recognizing her leadership, innovation, and research excellence. She was a winner of the ISEV Image Competition, celebrating creativity in extracellular vesicle research. She received the Cougar Cage Award from Washington State University for her promising EV-based antimicrobial proposal. Her leadership and academic excellence earned her the WSU President’s Award for Leadership and recognition as a WSU Woman of Distinction. These awards highlight not only her scientific contributions but also her dedication to community engagement, mentorship, and cross-disciplinary collaboration. Her ability to secure competitive funding, publish impactful research, and innovate at the intersection of biology and engineering underscores her qualifications for the Best Researcher Award.

Research Focus:

Dr. Marwa Aly’s research centers on extracellular vesicles (EVs) and their potential to combat antimicrobial resistance. Her recent focus is on stage-dependent EVs produced by Pseudomonas aeruginosa and algae, exploring their ability to disrupt biofilms and trigger ferroptosis in pathogenic organisms. Her research includes proteomic analysis, biofilm interaction studies, and in vivo wound infection models, advancing the understanding of EVs as therapeutic agents. Additionally, she has conducted microfluidic-based studies for biofuel optimization, developing innovative devices to study microalgae growth under various environmental conditions. Her work is grounded in translational science, bridging lab discoveries with industrial applications such as bioenergy and infection control. By integrating microbiology, bioengineering, and nanotech, she is at the forefront of next-generation biotechnologies, making substantial contributions to public health, sustainability, and microbial sciences.

Publications Top Notes:

  1. Algal Biofuels: Current Status and Key Challenges – Energies

  2. Exosomes as Powerful Engines in Cancer: Isolation, Characterization and Detection Techniques – Biosensors

  3. Evaluation of Storage Stability for Biocrude Derived from Hydrothermal Liquefaction of Microalgae – Energy & Fuels

  4. High-Throughput Screening of Chlorella Vulgaris Growth Kinetics in Microfluidics – Biomolecules

  5. Droplet-based Microfluidic Gradient for Chlorella Growth under Nitrogen & Temp Stress – Algal Research

  6. Impact of Nitrogen Regime on Fatty Acid Profiles of Algae for Biofuel – Acta Botanica Hungarica

  7. Dual Roles of Conditional Extracellular Vesicles from Pseudomonas Biofilms – Biofilm

  8. Phytochemical Screening and Antimicrobial Activity of Egyptian Green Algae – Journal of Medicinal Plants Studies

  9. Nitrogen Concentration Impact on Algal Biomass, Lipids & Biofuel Yield – IJSTR

  10. Challenges of Biodiesel Production from Oscillatoria sp. – IJAR

Conclusion:

In conclusion, Dr. Marwa Aly (Marwa Gamal Saad) is a highly qualified, driven, and impactful researcher who has made significant contributions across several vital scientific areas, from microbial therapeutics to renewable biofuels. Her dual-Ph.D. credentials, publication record, patent-pending research, competitive grant success, and multiple recognitions make her an excellent candidate for the Best Researcher Award. While she can further enhance her profile through increased international engagement and publication output, her current achievements already distinguish her as a rising leader in the fields of biotechnology, microbiology, and bioengineering. She is not only suitable but highly recommended for this recognition.

Shahab Uddin | Microbiology | Best Researcher Award

Published on by Cell Biologist

Mr. Shahab Uddin | Microbiology | Best Researcher Award

Mr. Shahab Uddin | Department of Life Sciences, Lanzhou University | China

Shahab Uddin, is a dedicated and accomplished microbiologist with a strong background in microbial ecology, molecular biology, and nanotechnology. He is currently pursuing a Ph.D. in Microbiology at Lanzhou University, China, where he is engaged in cutting-edge research involving antibiotic-conjugated magnetic nanoparticles for periodontitis diagnosis. With numerous international publications in high-impact journals and experience across microbiology, mechanobiology, and neuroinflammation research, Shahab is recognized for his exceptional technical skills and scientific contributions. His career has spanned various research institutions, including Sungkyunkwan University in South Korea, where he conducted pivotal studies on nanoparticles and microbial pathogens. Driven by scientific curiosity and a collaborative spirit, Shahab continues to contribute to advancements in microbial and biomedical research. Fluent in English, Urdu, and proficient in scientific communication, he is an ideal candidate for the Best Researcher Award, representing both innovation and perseverance in the life sciences.

Publication Profiles: 

Google Scholar
Orcid

Education:

Shahab Uddin began his academic journey in Pakistan, completing his M.Phil. in Microbiology from Quaid-I-Azam University, Islamabad. During his postgraduate studies, he specialized in microbial ecology and environmental microbiology. His thesis work laid the foundation for his deeper interest in microbial mechanisms and genetic interactions. He further advanced his academic credentials by enrolling in the Ph.D. Microbiology program at Lanzhou University, China. His doctoral research focuses on the application of nanotechnology in microbial diagnostics, specifically using magnetic nanoparticles for periodontal disease detection. Over the years, he has enhanced his technical skills in qPCR, molecular cloning, bioaerosol sampling, and nanoparticle synthesis. His education has been enriched by international collaborations and interdisciplinary exposure, especially in mechanobiology and neuroinflammation. Shahab’s education reflects a blend of foundational microbiology and cutting-edge biomedical research, enabling him to tackle complex scientific challenges with innovation and precision.

Experience:

Shahab Uddin has worked as a Research Assistant at Lanzhou University, actively contributing to a nanotechnology-driven project aimed at improving periodontitis diagnostics through magnetic nanoparticle conjugation. His work bridges microbiology, nanotechnology, and diagnostics, showcasing his interdisciplinary expertise. He has also conducted research under Prof. Sungsu Park at the 4DBM Laboratory, Sungkyunkwan University, South Korea, where he was responsible for nucleic acid extraction, synthesis of biocompatible nanoparticles, and detection of airborne pathogens. These roles reflect his strong command over laboratory techniques such as qPCR, microbial culturing, and nanoparticle formulation. His involvement in multiple international collaborations and multi-disciplinary projects highlights his ability to adapt and contribute meaningfully to diverse research environments. His excellent work ethic, dedication to scientific rigor, and impressive publication record position him as a highly experienced and innovative researcher, making him a suitable candidate for recognition such as the Best Researcher Award.

Awards and Honors:

Shahab Uddin has received notable academic recognitions throughout his career. During his early education, he was awarded a fellowship by Islamia Model College, Timergara, which covered his tuition and admission fees. He received a laptop through the Prime Minister’s Laptop Scheme at the University of Peshawar, acknowledging his academic merit and performance. His consistent involvement in internationally recognized research projects and publications in top-tier journals has brought him visibility and respect within the scientific community. His work on microbial calcium carbonate precipitation, nanoparticle toxicity, and Parkinson’s disease treatments has earned accolades in both ecological and biomedical research circles. Beyond formal awards, his participation in collaborative research in China and South Korea is a testament to his growing international reputation. These honors reflect his commitment to scientific advancement and his ability to represent his country and field at a global level.

Research Focus:

Shahab Uddin’s research focuses on the interface of microbiology, nanotechnology, and biomedical science. His doctoral work involves using antibiotic-conjugated magnetic nanoparticles for rapid and precise preconcentration of periodontal bacteria, a novel approach for periodontitis diagnosis. He has also investigated the neuroinflammatory effects of fusion proteins, the role of nicotine in neuroprotection in Parkinson’s disease, and microbial-induced calcium carbonate precipitation for environmental applications. Shahab’s interests include mechanobiology, microbial genetics, and pathogen detection using qPCR. He is particularly passionate about translating microbial research into diagnostic and therapeutic applications. His collaborations with institutions in South Korea and China reflect a global perspective and adaptability in interdisciplinary research. With a portfolio that includes molecular biology, environmental microbiology, and advanced nanomaterials, Shahab’s work stands at the forefront of modern microbiological science. His research bridges basic science and applied solutions, aiming to contribute to global health, sustainable environments, and innovative diagnostics.

Publications Top Notes: 

  1. A comparative study on HSA and α-MSH fusion proteins for anti-neuroinflammatory effects – Neuropeptides

  2. Rigid linker peptides enhance stability and anti-inflammatory efficacy of HSA-α-MSH fusions – Biotechnology Journal

  3. Autophagy and UPS pathway in nicotine-induced protection for Parkinson’s disease – Experimental Brain Research

  4. Nicotine-mediated therapy in transgenic C. elegans model for Parkinson’s – Frontiers in Aging Neuroscience

  5. Microbially induced calcium carbonate precipitation to improve soil mechanics – Ecological Engineering

  6. Psychrotolerant Serratia marcescens HI6 characterization from glacier – Applied Ecology & Environmental Research

  7. Retrospective study on tuberculosis incidence in Dir Lower, Pakistan – Hospital Pharmacy

  8. Mechanobiological analysis of nanoparticle toxicity – Nanomaterials

  9. Microfabricated devices to study tensile stress on cells and tissues – BioChip Journal

  10. Incidence of HBV, HCV, HIV among blood donors in Peshawar – Population

Conclusion:

In conclusion, Shahab Uddin is an outstanding and promising researcher with a broad and impactful academic portfolio. His contributions span critical scientific areas including microbial pathogenesis, nanotechnology-enabled diagnostics, and neurodegenerative disease models. His dedication, innovation, and consistency in research make him highly deserving of recognition through the Best Researcher Award. While there is scope for leadership expansion and broader outreach, his current achievements—especially his multi-disciplinary publications and international collaborations—are commendable and reflect a researcher who is not only productive but also forward-thinking. Granting him this award would not only honor his contributions but also inspire continued scientific excellence and innovation in microbiology and beyond.

Alejandro Rojas | Immunology Cellular Interactions | Best Researcher Award

Published on by Cell Biologist

Assist. Prof. Dr. Alejandro Rojas | Immunology Cellular Interactions | Best Researcher Award

Assist. Prof. Dr. Alejandro Rojas | Austral University of Chile | Germany

Dr. Alejandro Alfredo Rojas Fernández is a distinguished Chilean molecular biotechnologist and neuroscientist, currently serving as CEO of Berking Theranostics UG in Hamburg, Germany, and Assistant Professor at the Universidad Austral de Chile. With over two decades of research spanning neurodegeneration, immunology, and viral pathogenesis, Dr. Rojas-Fernández has emerged as a leading expert in molecular diagnostics and theranostics. His innovative work has significantly impacted global health, notably through his contributions to SARS-CoV-2 research and senolytic therapies. A dual academic and entrepreneur, he bridges fundamental science and clinical application, actively publishing in top-tier journals such as Nature Aging, Molecular Psychiatry, and Journal of Cell Biology. Fluent in interdisciplinary collaboration, his efforts have been internationally recognized with multiple honors. With a passion for translational science, Dr. Rojas-Fernández continues to inspire the next generation of biomedical innovators through mentorship and leadership in biotechnology and neuroscience.

Publication Profile:

Orcid

Education:

Dr. Alejandro Rojas-Fernández earned his PhD in Biology from the University of Konstanz, Germany (2006–2010), where his research focused on the regulation of Hdm2/HdmX-mediated ubiquitination and neddylation—mechanisms central to protein stability and cancer biology. Prior to his doctorate, he completed his engineering degree in Molecular Biotechnology (2004–2005) and his B.Sc. in Molecular Biotechnology Engineering (2000–2004) at the Faculty of Sciences, University of Chile—one of Latin America’s leading research institutions. His multidisciplinary education integrates molecular biology, neurobiology, immunology, and translational medicine, equipping him with the foundational and advanced tools to tackle complex biomedical challenges. Dr. Rojas-Fernández’s academic training has been marked by academic excellence and international mobility, enabling him to collaborate and lead research projects across Europe and Latin America.

Experience:

Dr. Rojas-Fernández brings over 20 years of experience in translational biomedical research, academia, and biotech innovation. As CEO of Berking Theranostics UG, he spearheads the development of personalized diagnostic platforms and therapeutics, with a focus on neurodegenerative and inflammatory diseases. In his role as Assistant Professor at Universidad Austral de Chile (20% appointment), he leads the Medical Biotechnology Laboratory within the Centre for Interdisciplinary Studies on the Nervous System (CISNe), contributing to scientific training and cutting-edge research. He previously trained and collaborated at institutions such as the University of Dundee, University of Queensland, and University of Constance, advancing molecular mechanisms of SUMOylation, proteostasis, inflammasome biology, and viral-host interactions. His interdisciplinary expertise allows him to translate complex cellular insights into tangible clinical applications, and his leadership has resulted in high-impact publications, product pipelines, and strategic biotech partnerships in Europe and Latin America.

Awards and Honors:

Dr. Rojas-Fernández has received multiple prestigious honors recognizing his innovative biomedical research. In February 2025, he was named “Innovator of the Month” by Hamburg Invest for groundbreaking biotech contributions in Germany. He was awarded the Medal of the City of Valdivia for his vital role in controlling the SARS-CoV-2 pandemic, one of the highest local honors in Chile. Additionally, he received the 2nd of October Medal for Science and Innovation, recognizing his scientific leadership in Chile’s Los Ríos region. These accolades underscore his impact on global public health, neurodegenerative research, and biotechnology entrepreneurship. His consistent recognition reflects a career dedicated to translational excellence, fostering international collaboration, and advancing science for the benefit of society. His scientific achievements continue to inspire innovation and interdisciplinary approaches within the global scientific community.

Research Focus:

Dr. Alejandro Rojas-Fernández’s research centers on cellular stress responses, ubiquitin/SUMO signaling, neurodegeneration, and host-pathogen interactions. A core focus is the molecular crosstalk between autophagy, protein quality control, and inflammasome activation in brain and immune cells. He has made significant advances in understanding the effects of SARS-CoV-2 on microglia, mechanisms of senescence in aging brains, and nanobody-based viral neutralization. His studies also explore the intersection of endoplasmic reticulum stress and neurodegenerative pathways, using high-content screening and proteomics to uncover therapeutic targets. He actively translates molecular insights into diagnostics and theranostic tools, positioning him at the forefront of personalized medicine. As CEO of a biotech startup, he is developing platforms that integrate biomarker discovery with AI for neuroinflammation profiling. His research bridges fundamental biology and clinical applications, promoting innovative therapies for Alzheimer’s, Parkinson’s, cancer, and viral infections.

Publications Top Notes: 

  1. Negative Modulation of Macroautophagy by Stabilized HERPUD1… – Front Cell Dev Biol, 2022

  2. SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia… – Mol Psychiatry, 2022

  3. The p97/VCP segregase is essential for arsenic-induced degradation of PML… – J Cell Biol, 2023

  4. Lack of Parkinsonian Pathology after Proteasome Inhibitor Injection… – Front Aging Neurosci, 2021

  5. NSPA modulates postsynaptic NMDAR stability… – BMC Biol, 2020

  6. Role of PSMD14 in Golgi-to-ER transport and APP processing – Cells, 2020

  7. WDR90 in NLRC4 inflammasome and Salmonella resistance – Dev Comp Immunol, 2019

  8. Proteomic identification of APC interaction partners – Mol Cancer Res, 2019

  9. DHX15 regulates CMTR1-dependent gene expression – Life Sci Alliance, 2018

  10.  Membrane ruffling by polarized stim1 and orai1 – Sci Reports, 2017

Conclusion:

Dr. Alejandro Alfredo Rojas Fernández stands out as a pioneering researcher who consistently delivers scientifically rigorous, socially impactful, and clinically relevant work. His career spans critical sectors—basic research, applied biotechnology, and public health—making him a model example of the translational scientist. With accolades from both European and Latin American institutions and a track record of high-impact publications, Dr. Rojas exemplifies what it means to be a globally relevant and community-driven scientist. His work during the COVID-19 pandemic, innovations in molecular neuroscience, and leadership in therapeutic biotechnology underscore his immense value to the global research community. In conclusion, he is not only a suitable but a highly deserving candidate for the Best Researcher Award.